Literature DB >> 14677040

Usefulness of technetium-99m tetrofosmin SPECT to detect abnormal myocardial perfusion in systemic lupus erythematosus or systemic sclerosis patients.

H-B Hsu, C-H Kao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14677040     DOI： 10.1007/s10067-003-0754-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.

Authors:  Arend F L Schinkel; Abdou Elhendy; Ron T van Domburg; Jeroen J Bax; Eleni C Vourvouri; Manos Bountioukos; Vittoria Rizzello; Eustachio Agricola; Roelf Valkema; Jos R T C Roelandt; Don Poldermans
Journal:  Am J Cardiol       Date:  2003-02-15       Impact factor: 2.778

2.  Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.

Authors:  P Flamen; A Bossuyt; P R Franken
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

3.  Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients.

Authors:  Leslee J Shaw; Robert Hendel; Salvador Borges-Neto; Michael S Lauer; Naomi Alazraki; Joy Burnette; Elizabeth Krawczynska; Manuel Cerqueira; Jamshid Maddahi
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

4.  Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging.

Authors:  J D Kelly; A M Forster; B Higley; C M Archer; F S Booker; L R Canning; K W Chiu; B Edwards; H K Gill; M McPartlin
Journal:  J Nucl Med       Date:  1993-02       Impact factor: 10.057

5.  Diversity of myocardial involvement in systemic sclerosis: an 8-year study of 95 Japanese patients.

Authors:  I Murata; K Takenaka; S Shinohara; T Suzuki; T Sasaki; K Yamamoto
Journal:  Am Heart J       Date:  1998-06       Impact factor: 4.749

6.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

Authors:  M Petri; S Perez-Gutthann; D Spence; M C Hochberg
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.